Dimensional Fund Advisors’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.9K | Hold |
34,923
| – | – | ﹤0.01% | 3238 |
|
|
2025
Q1 | $56.2K | Hold |
34,923
| – | – | ﹤0.01% | 3251 |
|
|
2024
Q4 | $44K | Sell |
34,923
-16,361
| -32% | -$20.6K | ﹤0.01% | 3300 |
|
|
2024
Q3 | $96.4K | Sell |
51,284
-60,585
| -54% | -$114K | ﹤0.01% | 3244 |
|
|
2024
Q2 | $828K | Sell |
111,869
-32,596
| -23% | -$241K | ﹤0.01% | 2936 |
|
|
2024
Q1 | $1.13M | Sell |
144,465
-2,972
| -2% | -$23.3K | ﹤0.01% | 2902 |
|
|
2023
Q4 | $749K | Sell |
147,437
-15,332
| -9% | -$77.9K | ﹤0.01% | 2982 |
|
|
2023
Q3 | $964K | Sell |
162,769
-17,376
| -10% | -$103K | ﹤0.01% | 2938 |
|
|
2023
Q2 | $1.34M | Sell |
180,145
-353
| -0.2% | -$2.62K | ﹤0.01% | 2876 |
|
|
2023
Q1 | $1.71M | Buy |
180,498
+16,578
| +10% | +$157K | ﹤0.01% | 2777 |
|
|
2022
Q4 | $1.75K | Buy |
163,920
+46,404
| +39% | +$494 | ﹤0.01% | 2759 |
|
|
2022
Q3 | $867K | Buy |
117,516
+90,212
| +330% | +$666K | ﹤0.01% | 2921 |
|
|
2022
Q2 | $131K | Hold |
27,304
| – | – | ﹤0.01% | 3293 |
|
|
2022
Q1 | $140K | Buy |
27,304
+1,195
| +5% | +$6.13K | ﹤0.01% | 3355 |
|
|
2021
Q4 | $157K | Buy |
26,109
+15,030
| +136% | +$90.4K | ﹤0.01% | 3377 |
|
|
2021
Q3 | $98K | Buy |
+11,079
| New | +$98K | ﹤0.01% | 3429 |
|